BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 3063486)

  • 1. Effects of antihypertensive therapy on kidney function in diabetic patients.
    Scherstén B
    Drugs; 1988; 35 Suppl 5():59-61. PubMed ID: 3063486
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Renal protection and antihypertensive drugs: current status.
    Salvetti A; Mattei P; Sudano I
    Drugs; 1999 May; 57(5):665-93. PubMed ID: 10353294
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent advances in pharmacological management of hypertension in diabetic patients with nephropathy. Effects of antihypertensive drugs on kidney function and insulin sensitivity.
    Baba T; Ishizaki T
    Drugs; 1992 Apr; 43(4):464-89. PubMed ID: 1377114
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of beta-blockade and angiotensin converting enzyme inhibition on kidney function in diabetic nephropathy.
    Hommel E
    J Hypertens Suppl; 1989 Sep; 7(7):S49-51. PubMed ID: 2575661
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The effect of angiotensin-converting enzyme inhibitors on the progression of chronic renal failure].
    Bernadet-Monrozies P; Rostaing L; Kamar N; Durand D
    Presse Med; 2002 Nov; 31(36):1714-20. PubMed ID: 12467154
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of antihypertensive drugs on renal function in patients with diabetic nephropathy.
    Bretzel RG
    Am J Hypertens; 1997 Sep; 10(9 Pt 2):208S-217S. PubMed ID: 9324124
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blood pressure lowering for the prevention and treatment of diabetic kidney disease.
    Thomas MC; Atkins RC
    Drugs; 2006; 66(17):2213-34. PubMed ID: 17137404
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Antihypertensive therapy in diabetes mellitus].
    Hess B
    Ther Umsch; 1999 Jan; 56(1):25-32. PubMed ID: 10067131
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Angiotensin II type-1 receptor antagonists and diabetes mellitus].
    Schnack C; Schernthaner G
    Wien Med Wochenschr; 2001; 151(7-8):165-8. PubMed ID: 11450165
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renal protection in diabetes--an emerging role for calcium antagonists.
    Parving HH; Tarnow L; Rossing P
    Cardiology; 1997; 88 Suppl 3():56-62. PubMed ID: 9397296
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevention and slowing down the progression of the diabetic nephropathy through antihypertensive therapy.
    Bretzel RG
    J Diabetes Complications; 1997; 11(2):112-22. PubMed ID: 9101397
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renal protection in hypertensive patients: selection of antihypertensive therapy.
    Wenzel RR
    Drugs; 2005; 65 Suppl 2():29-39. PubMed ID: 16398060
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The use of antihypertensive agents in prevention and treatment of diabetic nephropathy.
    Parving HH; Rossing P
    Curr Opin Nephrol Hypertens; 1994 May; 3(3):292-300. PubMed ID: 7922255
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of angiotensin converting enzyme inhibitors on the progression of diabetic nephropathy.
    Ruilope LM
    J Hypertens Suppl; 1995 Aug; 13(2):S91-3. PubMed ID: 8576796
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renal protection in diabetes: an emerging role for calcium antagonists.
    Parving HH; Tarnow L; Rossing P
    J Hypertens Suppl; 1996 Nov; 14(4):S21-5. PubMed ID: 8986939
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiotensin-converting enzyme inhibition and diabetic nephropathy.
    Beaufils M
    J Cardiovasc Pharmacol; 1992; 19 Suppl 6():S33-8. PubMed ID: 1382163
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Risk and prevention of diabetic nephropathy].
    Ravera M; Re M; Deferrari G
    G Ital Nefrol; 2007; 24 Suppl 38():13-9. PubMed ID: 17922442
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevention of loss of renal function over time in patients with diabetic nephropathy.
    Barnett A
    Am J Med; 2006 May; 119(5 Suppl 1):S40-7. PubMed ID: 16563947
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of angiotensin II receptor antagonists in the management of diabetes.
    Barnett AH
    Blood Press Suppl; 2001; 1():21-6. PubMed ID: 11333010
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Diabetic nephropathy and arterial hypertension: the physiopathological aspects and antihypertensive treatment].
    Savazzi GM; Castiglioni A
    Ann Ital Med Int; 1992; 7(3):160-4. PubMed ID: 1457255
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.